I | Alive n = 107 | Deceased n = 35 | p-value |
---|---|---|---|
Age | 46.9 ± 14.5 | 63.6 ± 10.9 | < 0.001 |
Gender, male % | 63.5 | 78.8 | 0.10 |
Time of follow up, months | 106 (101–111) | 76 (64–85) | < 0.001 |
Dialysis vintage, months ǂ | 7 (4–15) | 9 (3–23) | 0.32 |
Peritoneal dialysis, % | 23 | 15 | 0.31 |
Waitlisted for RTX, % | 68 | 60 | 0.40 |
Living donor, % | 29 | 17 | 0.17 |
Hypertension, % | 89 | 85 | 0.58 |
Cardiovascular disease, % | 11 | 31 | 0.005 |
Charlson comorbidity index | 4 (2–6) | 6 (5–7) | 0.001 |
Diabetes, % | 23 | 15 | 0.32 |
Body mass index, kg/m2 | 25.4 ± 4.4 | 25.7 ± 4.2 | 0.52 |
Systolic blood pressure, mmHg | 140 ± 20 | 148 ± 18 | 0.02 |
Diastolic blood pressure, mmHg | 81 ± 12 | 76 ± 10 | 0.05 |
Haemoglobin, g/dL | 12.3 ± 1.5 | 12.1 ± 1.4 | 0.30 |
Albumin, mmol/L | 39 (38–42) | 41 (37–43) | 0.53 |
Cause of end stage renal disease, % | |||
-Diabetic nephropathy | 15 | 0 | 0.02 |
-Nephrosclerosis | 14 | 32 | 0.02 |
-Glomerulonephritis | 33 | 21 | 0.52 |
-Inherited cystic kidney disease | 10 | 18 | 0.28 |
-Other | 27 | 29 | 0.82 |